Use of inhaled corticosteroids and the risk of cataracts

New England Journal of Medicine

Volumn 337, Issue 1, 1997, Pages 8-14

  Cumming, Robert G ^a   Mitchell, Paul ^a,b   Leeder, Stephen R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CATARACT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; CATARACT; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0030859363     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199707033370102     Document Type: Article

References (21)

1. Adamsons I, Munoz B, Enger C, Taylor HR. Prevalence of lens opacities in surgical and general populations. Arch Ophthalmol 1991;109:993-7.
2. Hodge WG, Whitcher JP, Satariano W. Risk factors for age-related cataracts. Epidemiol Rev 1995;17:336-46.
3. Black RL, Oglesby RB, von Sallmann L, Bunim JJ. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 1960;174:166-71.
4. Kewley GD. Possible association between beclomethasone diproprionate aerosol and cataracts. Aust Paediatr J 1980;16:117-8.
5. Simons FER, Persaud MP, Gillespie CA, Cheang M, Shuckett EP. Absence of posterior subcapsular cataracts in young patterns treated with inhaled glucocorticoids. Lancet 1993;342:776-8.
6. Abuekteish F, Kirkpatrick JNP, Russell G. Posterior subcapsular cataract and inhaled corticosteroid therapy. Thorax 1995;50:674-6.
7. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone diproprionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;92:64-77.
8. Toogood JH, Markov AE, Baskerville J, Dyson C. Association of ocular cataracts with inhaled and oral steroid therapy durmg long-term treatment of asthma J Allergy Clin Immunol 1993;91:571-9.
9. Nassif E, Weinberger M, Sherman B, Brown K. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chrome asthma. J Allergy Clin Immunol 1987;80:518-29.
10. Allen MB, Ray SG, Leitch AG, Dhillon B, Cullen B. Steroid aerosols and cataract formation. BMJ 1989;299:432-3.
11. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. Ophthalmology 1996;103:357-64.
12. Klein BEK, Klein R, Linton KLP, Magli YL, Neider MW. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology 1990;97:1428-33.
13. Klein BEK, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population. Ophthalmology 1992;99:546-52.
14. Mitchell P, Cumming RG, Attebo K, Panchapakesan J. Prevalence of cataract in Australia: the Blue Mountains Eye Study. Ophthalmology 1997; 104:581-8.
15. Panchapakesan I, Cumming RG, Mitchell P. Reproducibility of the Wisconsin Cataract Grading System in the Blue Mountains Eye Study. Ophthalmic Epidemiol (in press).
16. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986:17, 177, 346.
17. Armstrong BG, Sloan M. Ordinal regression models for epidemiologic data. Am J Epidemiol 1989;129:191-204.
18. Toogood JH, Jennings BH, Baskerville JC, Lefcoe NM. Aerosol corticosteroids. In: Weiss EB, Stein M, eds. Bronchial asthma: mechanisms and therapeutics. 3rd ed. Boston: Little, Brown, 1993:818-41.
19. Ip M, Lam K, Yam L, Kung A, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroid. Chest 1994;105:1722-7.
20. Urban RC Jr, Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol 1986;31:102-10.
21. Karim AK, Jacob TJ, Thompson GM. The human lens epithelium: morphological and ultrastructural changes associated with steroid therapy. Exp Eye Res 1989;48:215-24.